BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30

• Drug Development

  Bristol-Myers Squibb Company, AstraZeneca PLC Meet Study Goal

  September 9, 2008

   · 

  11 min read
• Drug Development

  Epiphany Biosciences, Inc. to Continue Phase 2 Shingles Study After Interim Analysis; Plans Follow-On Clinical Trial Studying Post-Herpetic Neuralgia

  September 9, 2008

   · 

  2 min read
• Business

  Asuragen, Inc. Signs Armored RNA(R) Licensing Agreement with Focus Diagnostics, Inc.

  September 9, 2008

   · 

  2 min read
• Biotech Bay

  Jennerex Completes $8.3 Million Series B Financing

  September 9, 2008

   · 

  4 min read
• Polymathic Analytical Labs Announces Zeus Webinar Polymer Characterization

  September 9, 2008

   · 

  2 min read
• BioCapital

  Spherix to Seek Stockholder Approval of Reverse Stock Split

  September 9, 2008

   · 

  2 min read
• Business

  Rib-X Pharmaceuticals, Inc. Announces Formation of Clinical Advisory Board

  September 9, 2008

   · 

  4 min read
• Business

  Metabolon Welcomes Edward L. Erickson to Its Board of Directors

  September 9, 2008

   · 

  1 min read
• Biotech Bay

  VIVUS, Inc. to Present at the Merriman Curhan Ford Investor Summit 2008

  September 9, 2008

   · 

  1 min read
• Lone Star Bio

  Manufacturer of Innovative Zeno Acne Treatment Device Announces Corporate Name Change Tyrell, Inc. becomes Zeno Corporation

  September 9, 2008

   · 

  1 min read